Get the app!
Back to Trades

Thompson Peter A.

DirectorCIK 0001357522

Largest Purchase

No open-market purchases in the recent filings.

Profile

Filings
14
Buy transactions
0
Sell transactions
17
Companies
4
Active
2025–2026

Across 14 filings between 2025–2026, Thompson Peter A., Director, has disclosed $59.5M in transactions — spread across 4 companies. Their disclosed trades are heavily weighted toward selling$0 in buys and $55.6M in sells. Data is sourced from official SEC Form 3, 4, and 5 filings.

Trading History

14 loaded
Jul 9SION
Sionna Therapeutics, Inc.
Thompson Peter A.DirectorSell$3.9M
Jul 2SION
Sionna Therapeutics, Inc.
Thompson Peter A.DirectorSell$5.3M
Jun 26SPRY
ARS Pharmaceuticals, Inc.
Thompson Peter A.InsiderAward$316.2K
Jun 18SION
Sionna Therapeutics, Inc.
Thompson Peter A.DirectorAward$636.9K
Jun 17EWTX
Edgewise Therapeutics, Inc.
Thompson Peter A.InsiderAward$582.9K
Jun 15CRVS
Corvus Pharmaceuticals, Inc.
Thompson Peter A.InsiderAward$174.0K
May 29SION
Sionna Therapeutics, Inc.
Thompson Peter A.DirectorSell$4.5K
May 11SION
Sionna Therapeutics, Inc.
Thompson Peter A.DirectorSell$13.4M
Apr 21SION
Sionna Therapeutics, Inc.
Thompson Peter A.DirectorSell$2.5M
Apr 16SION
Sionna Therapeutics, Inc.
Thompson Peter A.DirectorSell$22.9M
Feb 4SION
Sionna Therapeutics, Inc.
Thompson Peter A.DirectorSell$1.4M
Jan 30CRVS
Corvus Pharmaceuticals, Inc.
Thompson Peter A.Director, 10% OwnerExercise$2.2M
Dec 29SION
Sionna Therapeutics, Inc.
Thompson Peter A.DirectorSell$1.5M
Nov 26SION
Sionna Therapeutics, Inc.
Thompson Peter A.DirectorSell$4.8M

14 filings